Smoking Cessation Aids Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Smoking Cessation Aids Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Smoking Cessation Aids Market is expected to witness a CAGR of 12.5% during the forecast period. Smoking is one of the major causes of lung cancer and other respiratory and cardiac diseases. Awareness about these health hazards has influenced the individuals to adopt smoking cessation therapy. The awareness among the individuals is through digital media, print media and other sources of information has proved to be effective in curbing nicotine addiction crisis to some extent.

Cigarette smoking remains the leading cause of preventable disease, disability, and death. According to Centers for Disease Control and Prevention (CDC), In 2019, nearly 14 of every 100 U.S. adults aged 18 years or older (14.0%) smoked cigarettes. This hints at a high usage of de-addiction products. Also, this depicts the growing awareness of the people and their readiness to quit smoking. There are also non-government and government establishments working to educate and help people quit smoking that is engaged dedicatedly, to bring the number of smokers down. For instance, in 2017, the US Food and Drug Administration launched an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit smoking.

Other factors that will help the market growth during the forecast period, include the introduction of new products and reimbursement for smoking cessation therapy.

Key Market TrendsE-cigarettes Technology is Expected to Show Steady Growth Over the Forecast Period

E-cigarettes are considered as a healthy alternative to tobacco cigarettes and is estimated to be the fastest growing segment over the forecast period. E-cigarettes are an effective alternative for reducing health conditions associated with tobacco, while nicotine replacement therapies work best for smoking cessation. E-cigarettes are a potential threat to tobacco-based cigarettes.

At the same time, an opportunity for tobacco manufacturers to enter the new emerging segment catering to the smoking population. Consumption of e-cigarettes are less harmful compared to the regular cigarettes, no smoke and no risk of passive smoking, allowed to use even in no-smoking places, varying nicotine levels, and availability in various flavors are some of the major driving factors for the e-cigarettes market. in addition, the increasing popularity of e-cigarettes backed by its electronic feature is considered to be the major factor contributing towards its increasing demand.

Asia-Pacific Expected to Expected to Show Fastest Growth over the Forecast Period

Asia-Pacific is expected to be the fastest growing region for the market, due to increasing awareness about the smoking cessation and nicotine de-addiction products, and a huge population base in the area. In a study called Tobacco Smoking and Mortality in Asia published by JAMA Network March 2019, a pooled meta-analysis, an international collaboration of researchers, led by those from Vanderbilt University, United States, has studied the trends in tobacco use in China, Japan, South Korea, Singapore, Taiwan, and India. It was estimated that 8.3 million deaths will be attributed to smoking by 2030, half of the world's male smokers live in China, India, and Indonesia and Asia is the world's largest tobacco consumer and producer.

North America is also found dominating the smoking cessation market due to the established healthcare infrastructure and the rising disposable income.

Competitive Landscape

The market players in the smoking cessation aids market involve various growth strategies, such as collaborations, partnerships, agreements, mergers and acquisitions in order to enhance the market presence. Furthermore, the introduction of new products, collaborations with government and NGO's to create awareness of smoking cessation also boosts the market growth.

Additional Benefits:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Companies Mentioned

IBM Corporation
Oracle Corporation
Internap Corporation
Packet Inc. (An Equinix Inc. Company)
Scaleway Inc.
Amazon Web Services Inc
Rackspace Inc.
CenturyLink, Inc.
LightEdge Solutions, Inc

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Large Population Addicted to Smoking
4.2.2 Awareness on Hazards of Smoking
4.2.3 Banning Advertisements of Tobacco Products
4.3 Market Restraints
4.3.1 Adverse effects of Drugs
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 Product
5.1.1 Nicotine Replacement Therapy
5.1.1.1 NRT Gum
5.1.1.2 NRT lozenges
5.1.1.3 NRT Inhalers
5.1.1.4 NRT Patches
5.1.1.5 Sprays
5.1.2 Drugs
5.1.3 Electronic Cigarettes
5.1.4 Others
5.2 End-user
5.2.1 Hospital Pharmacies
5.2.2 Online Channel
5.2.3 Retail Pharmacies
5.2.4 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 NJOY
6.1.2 Pfizer Inc.
6.1.3 GlaxoSmithKline Plc
6.1.4 F. Hoffmann-La Roche AG
6.1.5 Novartis AG
6.1.6 Johnson and Johnson
6.1.7 Bayer AG
6.1.8 Cipla Ltd
6.1.9 Takeda Pharmaceuticals Co. Ltd.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings